These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 28043639)

  • 1. Identification of novel Mycobacterium tuberculosis dihydrofolate reductase inhibitors through rational drug design.
    Akhter M
    Int J Mycobacteriol; 2016 Dec; 5 Suppl 1():S96. PubMed ID: 28043639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three-dimensional structure of M. tuberculosis dihydrofolate reductase reveals opportunities for the design of novel tuberculosis drugs.
    Li R; Sirawaraporn R; Chitnumsub P; Sirawaraporn W; Wooden J; Athappilly F; Turley S; Hol WG
    J Mol Biol; 2000 Jan; 295(2):307-23. PubMed ID: 10623528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The identification of novel Mycobacterium tuberculosis DHFR inhibitors and the investigation of their binding preferences by using molecular modelling.
    Hong W; Wang Y; Chang Z; Yang Y; Pu J; Sun T; Kaur S; Sacchettini JC; Jung H; Lin Wong W; Fah Yap L; Fong Ngeow Y; Paterson IC; Wang H
    Sci Rep; 2015 Oct; 5():15328. PubMed ID: 26471125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-based design, synthesis and preliminary evaluation of selective inhibitors of dihydrofolate reductase from Mycobacterium tuberculosis.
    El-Hamamsy MH; Smith AW; Thompson AS; Threadgill MD
    Bioorg Med Chem; 2007 Jul; 15(13):4552-76. PubMed ID: 17451962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural and Dynamics Perspectives on the Binding of Substrate and Inhibitors in Mycobacterium tuberculosis DHFR.
    Sittikornpaiboon P; Toochinda P; Lawtrakul L
    Sci Pharm; 2017 Sep; 85(3):. PubMed ID: 28914808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of novel selective Mtb-DHFR inhibitors as antitubercular agents through structure-based computational techniques.
    Sharma K; Neshat N; Sharma S; Giri N; Srivastava A; Almalki F; Saifullah K; Alam MM; Shaquiquzzaman M; Akhter M
    Arch Pharm (Weinheim); 2020 Feb; 353(2):e1900287. PubMed ID: 31867798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis, and antifolate activity of new analogues of piritrexim and other diaminopyrimidine dihydrofolate reductase inhibitors with omega-carboxyalkoxy or omega-carboxy-1-alkynyl substitution in the side chain.
    Chan DC; Fu H; Forsch RA; Queener SF; Rosowsky A
    J Med Chem; 2005 Jun; 48(13):4420-31. PubMed ID: 15974594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystal structure of chicken liver dihydrofolate reductase complexed with NADP+ and biopterin.
    McTigue MA; Davies JF; Kaufman BT; Kraut J
    Biochemistry; 1992 Aug; 31(32):7264-73. PubMed ID: 1510919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 6-Substituted 2,4-diaminopyrido[3,2-d]pyrimidine analogues of piritrexim as inhibitors of dihydrofolate reductase from rat liver, Pneumocystis carinii, and Toxoplasma gondii and as antitumor agents.
    Gangjee A; Zhu Y; Queener SF
    J Med Chem; 1998 Nov; 41(23):4533-41. PubMed ID: 9804692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural comparison of Mtb-DHFR and h-DHFR for design, synthesis and evaluation of selective non-pteridine analogues as antitubercular agents.
    Sharma K; Tanwar O; Sharma S; Ali S; Alam MM; Zaman MS; Akhter M
    Bioorg Chem; 2018 Oct; 80():319-333. PubMed ID: 29986181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural analysis of dihydrofolate reductases enables rationalization of antifolate binding affinities and suggests repurposing possibilities.
    Bhosle A; Chandra N
    FEBS J; 2016 Mar; 283(6):1139-67. PubMed ID: 26797763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2,4-Diamino-5-benzylpyrimidines as antibacterial agents. 7. Analysis of the effect of 3,5-dialkyl substituent size and shape on binding to four different dihydrofolate reductase enzymes.
    Roth B; Rauckman BS; Ferone R; Baccanari DP; Champness JN; Hyde RM
    J Med Chem; 1987 Feb; 30(2):348-56. PubMed ID: 3100802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-idiotypic antibodies elicited by pterin recognize active site epitopes in dihydrofolate reductases and dihydropteridine reductase.
    Ratnam S; Ratnam M; Cotton RG; Jennings IG; Freisheim JH
    Arch Biochem Biophys; 1989 Dec; 275(2):344-53. PubMed ID: 2480746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A proposed model of Mycobacterium avium complex dihydrofolate reductase and its utility for drug design.
    Kharkar PS; Kulkarni VM
    Org Biomol Chem; 2003 Apr; 1(8):1315-22. PubMed ID: 12929661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Further studies on 2,4-diamino-5-(2',5'-disubstituted benzyl)pyrimidines as potent and selective inhibitors of dihydrofolate reductases from three major opportunistic pathogens of AIDS.
    Rosowsky A; Forsch RA; Queener SF
    J Med Chem; 2003 Apr; 46(9):1726-36. PubMed ID: 12699390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crystal structures of Escherichia coli dihydrofolate reductase complexed with 5-formyltetrahydrofolate (folinic acid) in two space groups: evidence for enolization of pteridine O4.
    Lee H; Reyes VM; Kraut J
    Biochemistry; 1996 Jun; 35(22):7012-20. PubMed ID: 8679526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. X-ray crystallographic studies of Candida albicans dihydrofolate reductase. High resolution structures of the holoenzyme and an inhibited ternary complex.
    Whitlow M; Howard AJ; Stewart D; Hardman KD; Kuyper LF; Baccanari DP; Fling ME; Tansik RL
    J Biol Chem; 1997 Nov; 272(48):30289-98. PubMed ID: 9374515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DihydrofolateReductase (DHFR) Inhibitors: A Comprehensive Review.
    Sehrawat R; Rathee P; Khatkar S; Akkol E; Khayatkashani M; Nabavi SM; Khatkar A
    Curr Med Chem; 2023 Mar; ():. PubMed ID: 36896902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structures of dihydrofolate reductase-thymidylate synthase of Trypanosoma cruzi in the folate-free state and in complex with two antifolate drugs, trimetrexate and methotrexate.
    Senkovich O; Schormann N; Chattopadhyay D
    Acta Crystallogr D Biol Crystallogr; 2009 Jul; 65(Pt 7):704-16. PubMed ID: 19564691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.